Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13284
Peer-review started: August 31, 2022
First decision: October 20, 2022
Revised: November 5, 2022
Accepted: December 9, 2022
Article in press: December 9, 2022
Published online: December 26, 2022
Processing time: 117 Days and 8.1 Hours
Rectal cancer is characterized by more local recurrence and lung metastasis than colon cancer. However, the diagnosis of rectal cancer is not standardized as there is no global consensus on its definition and classification. The classification of rectal cancer differs between Japanese and Western guidelines.
To clarify the characteristics of rectal cancer by comparing the tumor location and characteristics of rectal cancer with those of colon cancer according to each set.
To make the management of rectal cancer a common understanding and to help determine the optimal treatment strategy. To that end, each guideline was compared.
A total of 958 patients with Stage II and III colorectal cancer were included in the analysis: 607 with colon cancer and 351 with rectal cancer. Localization of rectal cancers was assessed by enema examination and rigid endoscopy.
Rectal cancer, which is indicated for chemoradiotherapy in the Western country, is consistent with middle-lower rectal cancer in Japan, and the recurrence rate was characterized by local recurrence and lung metastasis more than colon cancer.
High rectal cancer may be treated with the same treatment strategies as colon cancer. There was no difference in the classification of colorectal cancer between Japan and Western countries.
Chemoradiotherapy and lateral lymph node dissection are available for rectal cancer. Although many studies are being conducted around the world, clarifying the correct diagnosis will help in selecting the optimal treatment.
